Gerald T Proehl - Net Worth and Insider Trading
Gerald T Proehl Net Worth
The estimated net worth of Gerald T Proehl is at least $14,673 dollars as of 2024-11-29. Gerald T Proehl is the President, CEO and Chairman, 10% Owner of Dermata Therapeutics Inc and owns about 13,252 shares of Dermata Therapeutics Inc (DRMA) stock worth over $14,577. Gerald T Proehl is the Director of Ritter Pharmaceuticals Inc and owns about 200 shares of Ritter Pharmaceuticals Inc (RTTR) stock worth over $90. Gerald T Proehl is also the Director of Tenax Therapeutics Inc and owns about 1 shares of Tenax Therapeutics Inc (TENX) stock worth over $5. Details can be seen in Gerald T Proehl's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gerald T Proehl has not made any transactions after 2021-11-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gerald T Proehl
Gerald T Proehl Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gerald T Proehl owns 5 companies in total, including Tenax Therapeutics Inc (TENX) , Sophiris Bio Inc (SPHS) , and Ritter Pharmaceuticals Inc (RTTR) among others .
Click here to see the complete history of Gerald T Proehl’s form 4 insider trades.
Insider Ownership Summary of Gerald T Proehl
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TENX | Tenax Therapeutics Inc | 2016-11-23 | director |
| SPHS | Sophiris Bio Inc | 2019-06-27 | director |
| RTTR | Ritter Pharmaceuticals Inc | 2018-01-23 | director |
 | | 2015-06-24 | director |
| | 2021-11-23 | 10 percent owner & Pres. & CEO and Chairman |
Gerald T Proehl Latest Holdings Summary
Gerald T Proehl currently owns a total of 3 stocks. Among these stocks, Gerald T Proehl owns 13,252 shares of Dermata Therapeutics Inc (DRMA) as of November 23, 2021, with a value of $14,577 and a weighting of 99.35%. Gerald T Proehl owns 200 shares of Ritter Pharmaceuticals Inc (RTTR) as of June 24, 2015, with a value of $90 and a weighting of 0.61%. Gerald T Proehl also owns 1 shares of Tenax Therapeutics Inc (TENX) as of November 23, 2016, with a value of $5 and a weighting of 0.04%.
Latest Holdings of Gerald T Proehl
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DRMA | Dermata Therapeutics Inc | 2021-11-23 | 13,252 | 1.10 | 14,577 |
| RTTR | Ritter Pharmaceuticals Inc | 2015-06-24 | 200 | 0.45 | 90 |
| TENX | Tenax Therapeutics Inc | 2016-11-23 | 1 | 5.33 | 5 |
Holding Weightings of Gerald T Proehl
Gerald T Proehl Form 4 Trading Tracker
According to the SEC Form 4 filings, Gerald T Proehl has made a total of 2 transactions in Dermata Therapeutics Inc (DRMA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Dermata Therapeutics Inc is the acquisition of 83 shares on November 23, 2021, which cost Gerald T Proehl around $48,000.
According to the SEC Form 4 filings, Gerald T Proehl has made a total of 0 transactions in Ritter Pharmaceuticals Inc (RTTR) over the past 5 years. The most-recent trade in Ritter Pharmaceuticals Inc is the acquisition of 200 shares on June 24, 2015, which cost Gerald T Proehl around $250,000.
According to the SEC Form 4 filings, Gerald T Proehl has made a total of 0 transactions in Tenax Therapeutics Inc (TENX) over the past 5 years. The most-recent trade in Tenax Therapeutics Inc is the acquisition of 1 shares on November 23, 2016, which cost Gerald T Proehl around $49,903.
Insider Trading History of Gerald T Proehl
- 1
Gerald T Proehl Trading Performance
GuruFocus tracks the stock performance after each of Gerald T Proehl's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gerald T Proehl is -38.75%. GuruFocus also compares Gerald T Proehl's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gerald T Proehl within 3 months outperforms 0 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gerald T Proehl's insider trading performs compared to the benchmark.
Performance of Gerald T Proehl
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -6.85 | | | | | |
| Relative Return to S&P 500(%) | -7.28 | | | | | |
Gerald T Proehl Ownership Network
Gerald T Proehl Owned Company Details
What does Tenax Therapeutics Inc do?
Who are the key executives at Tenax Therapeutics Inc?
Gerald T Proehl is the director of Tenax Therapeutics Inc. Other key executives at Tenax Therapeutics Inc include Interim CFO Eliot M Lurier , director & CEO Chrisopher Thomas Giordano , and Chief Medical Officer Stuart Rich .
Tenax Therapeutics Inc (TENX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Tenax Therapeutics Inc (TENX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tenax Therapeutics Inc (TENX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Tenax Therapeutics Inc (TENX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tenax Therapeutics Inc Insider Transactions
Gerald T Proehl Mailing Address
Above is the net worth, insider trading, and ownership report for Gerald T Proehl. Currently GuruFocus does not have mailing address information for Gerald T Proehl.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
